Will Monsanto (NYSE:MON) Benefit from GM System Changes in EU?

While ultimately all companies producing and selling genetically modified (GM) seed will benefit, it's thought that Monsanto (NYSE:MON) could be the chief beneficiary of the proposed changes in the European Union approval system.

With some like Goldman Sachs' (NYSE:GS) analyst Robert Koort believing the bad news related to Monsanto is "exhausted," it could be a good step toward a long-term positive outlook for the company and industry.

The basics of the new proposal are to to make it easier to approve new GM varieties in Europe, while at the same time broadening the powers of EU governments in deciding if they will allow the seed and crops to be grown in their prospective countries.

This is good news for Monsanto in that even if a few countries approve of their products it could be a major breakthrough in the region for them, as there has only been two GM crops approved in the EU in a decade, with a potato being a recent one.

Monsanto could benefit from this over the long-term, as in the near term it's not likely to have much impact other then the future potential included with the changes.